Skip Navigation

European Heart Journal 1994 15(11):1537-1544;
Copyright © 1994 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by HOLDRIGHT, D. R.
Right arrow Articles by COLLINS, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOLDRIGHT, D. R.
Right arrow Articles by COLLINS, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 The European Society of Cardiology

The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy

D. R. HOLDRIGHT, D. CLARKE, K. FOX, P. A. POOLE-WILSON and P. COLLINS

National Heart and Lung Institute, and The Royal Brompton National Heart and Lung Hospital London, U.K

Received 17 February 1994; revised 27 May 1994; .

Correspondence: Diana R Holdright, The London Chest Hospital, Bonner Road, London E2 9JX, U.K.

Abstract

Attenuation of the increase in blood flow caused by acetylcholine in the peripheral vasculature and coronary circulation of patients with heart failure has been interpreted as an impairment of endothelium-dependent vasodilation. The aim of this study was to compare in man the effects of acetylcholine, which also has endothelium-independent actions, with substance P, which appears to be a pure endothelium-dependent vasodilator, on epicardial and resistance coronary arteries in patients with idiopathic dilated cardiomyopathy.

The effects of intracoronary acetylcholine (101M and 10–6M) and substance P (5, 10 and 25 pmol. min–1) on epicardial coronary artery diameter and coronary blood flow velocity were measured with an intracoronary Doppler flow probe and quantitative coronary angiography in 11 patients with idiopathic dilated cardiomyopathy and 10 control subjects.

Epicardial coronary artery diameter did not change with acetylcholine but increased significantly with substance P in both groups (cardiomyopathy patients: 3.3 ± 0.2 mm (mean ± SEM) at baseline vs 3.9 ± 0.2 mm with substance P 25 pmol. min–1, P<0.01, controls: 3.1± 0.2 mm at baseline vs 3.9 ± 0.3 mm with substance P 25 pmol. min–1, P<0.05). Coronary flow ratios with acetylcholine were lower in cardiomyopathy patients (10–7m: 1.4± 0.1 vs 2.3 ± 0.4, P=0.05; 10–6M: 1.8 ± 0.2 vs 3.2 ± 0.5, P=0.05 vs controls). Coronary flow ratios with substance P 5, 10 and 25 pmol. min–1 were 1.5 ± 0.1 vs 1.5± 0.1, l.8 ± 0.2 vs 2.2 ± 0.2 and 2.1 ±0.2 vs2.8 ± 0.3 (P=NS, cardiomyopathy patients vs controls respectively).

Whereas epicardial coronary artery responses to acetylcholine and substance P are similar in patients with dilated cardiomyopathy and control subjects, the actions of acetylcholine and substance P on coronary resistance vessels differ. The impairment with acetylcholine has several components, related either to muscarinic receptorltransduction mechanisms or the production of other vasoactive compounds, rather than a simple inability of the vascular endothelium to cause vasodilation.

Key Words: Dilated cardiomyopathy • endothelium derived relaxing factor • substance P acetylcholine • coronary blood flow


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
J. Gellman, J. M. Hare, C. J. Lowenstein, G. Gerstenblith, V. Coombs, P. Langenberg, J. A. Brinker, and J. R. Resar
L-Arginine Ameliorates the Abnormal Sympathetic Response of the Dysfunctional Human Coronary Microvasculature
Angiology, January 1, 2004; 55(1): 1 - 8.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
J. H Traverse, Y. Chen, M. Crampton, S. Voss, and R. J Bache
Increased extravascular forces limit endothelium-dependent and -independent coronary vasodilation in congestive heart failure
Cardiovasc Res, December 1, 2001; 52(3): 454 - 461.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. E. Loke, C. M. L. Curran, E. J. Messina, S. K. Laycock, E. G. Shesely, O. A. Carretero, and T. H. Hintze
Role of Nitric Oxide in the Control of Cardiac Oxygen Consumption in B2-Kinin Receptor Knockout Mice
Hypertension, October 1, 1999; 34(4): 563 - 567.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Schulze-Neick, D. J. Penny, M. L. Rigby, C. Morgan, A. Kelleher, P. Collins, J. Li, A. Bush, E. A. Shinebourne, and A. N. Redington
L-Arginine and Substance P Reverse the Pulmonary Endothelial Dysfunction Caused by Congenital Heart Surgery
Circulation, August 17, 1999; 100(7): 749 - 755.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. A. Mathier, G. A. Rose, M. A. Fifer, M. I. Miyamoto, R. E. Dinsmore, H. H. Castano, G. W. Dec, I. F. Palacios, and M. J. Semigran
Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 216 - 224.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.